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What is already known about this topic? 
・ LL-37 enhances DNA uptake into intracellular compartments, which leads to TLR9- 
and TLR7-dependent overproduction of IFNs in dendritic cells 
・ In keratinocytes, LL-37 enhances TLR9 responsiveness. 
・ LL-37 modulates poly (I:C)-induced proinflammatory responses in keratinocytes.  
What does this study add? 
・ LL-37 enhances IFN- expression and anti-viral activity induced by poly (I:C) in 
keratinocytes. 
  
  
 Abstract 
Background: Cathelicidin antimicrobial peptide LL-37 not only has the capacity to kill 
a wide variety of microbes, but also can modify host immunity. Recently our group has 
observed that the activation of keratinocytes by LL-37 and DNA greatly increases 
IFN- through Toll-like receptor 9 (TLR9). On the other hand, the effect of LL-37 on 
IFN- induction through TLR3, a sensor of double-stranded RNA, in keratinocytes is 
not well-known.  
Objectives: To investigate whether LL-37 could affect TLR3 signaling and anti-viral 
activity in normal human epidermal keratinocytes (NHEKs).  
Methods: We investigated IFN- production in NHEKs stimulated with a TLR3 ligand, 
poly (I:C), in the presence of LL-37. To examine the effect of LL-37 and poly (I:C) on 
anti-viral activity, a virus plaque assay using herpes simplex (HS) virus type-1 was 
carried out. The uptake of poly (I:C) conjugated with FITC into the keratinocytes was 
observed in the presence of LL-37. Immunostaining for TLR3 and LL-37 was 
performed using skin samples from HS. 
Results: LL-37 and poly (I:C) synergistically induced IFN- expression in NHEKs. 
Furthermore, the co-stimulation with LL-37 and poly (I:C) significantly decreased the 
viral plaque numbers compared to poly (I:C) or LL-37 alone. LL-37 enhanced the 
uptake of FITC-conjugated poly (I:C) into the cells. The immunohistochemical analysis 
demonstrated that TLR3 and LL-37 expression is up-regulated in lesions of HS.    
Conclusion: Our findings suggested that LL-37 augments the anti-viral activity induced 
by double-stranded RNA in keratinocytes, which may contribute to the innate immune 
response to cutaneous viral infections such as HS. 
  
Introduction 
Skin is our first physical barrier against pathogens from the external environment. The 
innate immune systems immediately respond to prevent further invasion.1 Antimicrobial  
peptides play an important role in innate immunity, and human epidermal keratinocytes 
produce a variety of antimicrobial peptides, including human -defensin (HBD) and 
cathelicidin.1 Cathelicidin antimicrobial peptide LL-37, a C-terminal 37-residue peptide 
derived from hCAP18, not only has the capacity to kill a wide variety of microbes, but 
also can modify host immune and growth responses.1 On the other hand, Toll-like 
receptors (TLRs) play an essential role in the recognition of microbial components,2 and 
10 members of TLRs have been reported in human.3-7 Among them TLR3, TLR7 and 
TLR8 are thought to be an important receptors in activating natural immune responses 
against viral infection.2,8,9 TLR3 recognizes double-stranded RNA which is synthesized 
during viral replication,10 which induces the activation of NF-B and the production of 
type I interferons (IFNs).8  Recently our group observed that the activation of 
keratinocytes by LL-37 and DNA greatly increase type I IFN through TLR9.11 However, 
the effect of LL-37 on IFN- induction through TLR3 signaling in keratinocytes has not 
been studied, although several groups have reported LL-37 modulates poly (I:C) (a 
synthetic analog of viral double-stranded RNA, TLR3 ligands)-induced immune 
responses in keratinocytes.12,13 Therefore we investigated whether LL-37 could affect 
IFN- induction through TLR3 signaling in normal human epidermal keratinocytes 
(NHEKs). 
 
Materials and methods 
Cell culture and stimuli 
NHEKs were obtained from Invitrogen/Cascade Biologics (Portland, OR, U.S.A.) and 
maintained in serum-free Epilife Medium containing 0.06 mM Ca²⁺, 1× Epilife Defined 
Growth Supplement (EDGS; Cascade Biologics/Invitrogen), 100 U ml⁻¹ penicillin and 
50 g ml⁻¹ streptomycin. Cells were maintained in a humidified atmosphere of 5% CO₂ 
at 37 C, and the medium was replaced every 2 days. Subconfluent NHEK monolayers 
were cultivated in 24-well plates and then stimulated with LL-37 (Peptide Institute. Inc., 
Osaka, Japan), poly (I:C) (InvivoGen, San Diego, CA, U.S.A.) or their combination for 
3 to 48 hours.  
 
Immunohistochemistry 
This study was approved by the Ethics Committee of Okayama University (No.1087). 
Human skin samples were collected from patients with herpes simplex and from healthy 
volunteers at Okayama University Hospital. Informed consent was obtained for all 
procedures. Formalin-fixed, paraffin-embedded skin samples were cut into 4 m 
sections.  Deparaffinized sections were processed for rehydration, incubated with a 
peroxidase-blocking reagent for 5 min and incubated with mouse monoclonal 
anti-TLR3 antibody (Abcam, Cambridge, MA, U.S.A.) or rabbit polyclonal anti-LL37 
antibody (Novus Biologicals, Littleton, CO, U.S.A.) at 4 C overnight. After washing 
with PBS, sections were incubated with secondary antibody conjugated with 
streptavidin-HRP for 30 min at room temperature. Histochemical visualization was 
carried out with an LSAB 2 kit (Dako, Carpinteria, CA, U.S.A.) according to the 
manufacturer’s instructions.  
 
Quantitative real-time PCR 
Total RNA was extracted from NHEKs using TRIzol reagent (Invitrogen Life 
Technologies, Carlsbad, CA, U.S.A.), and converted to cDNA using an iScript cDNA 
Synthesis Kit (BioRad, Hercules, CA, U.S.A.) as described by the manufacturer’s 
protocol. TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, 
U.S.A.) were used to analyze the expression of human IFNB1 (assay ID: 
Hs01077958_s1), IL6 (assay ID: Hs00985639_m1), IL8 (assay ID: Hs00174103_m1),  
CCL5 (assay ID: Hs00982282_m1), TLR3 (assay ID: Hs00152933_m1), DDX58 (assay 
ID: Hs00204833_m1), and IFIH1 (assay ID: Hs01070332_m1) as described by the 
manufacturer’s instructions (the user bulletin provided by Applied Biosystems). 
GAPDH mRNA was detected using the probe  
VIC-CATCCATGACAACTTTGGTA-MGB and the primers 
5’-CTTAGCACCCCTGGCCAAG-3’ and 5’-TGGTCATGAGTCCTTCCACG-3, and 
was used as an internal control to validate RNA for each sample.14 The expression level 
of each mRNA was calculated relative to that of GAPDH mRNA, and all data are 
presented as the fold change against the respective control (mean of non-stimulated 
cells).  
 
ELISA 
IFN-β protein in the NHEK culture media was measured by a commercial sandwich 
ELISA (PBL Interferon-Source, Piscataway, NJ, U.S.A.) following the manufacturer’s 
instructions.  
 
Virus plaque assays 
Wild-type herpes simplex virus type 1 (HSV-1, KOS strain) was obtained from the 
Research Institute for Microbial Diseases, Osaka University. Subconfluent NHEK 
monolayers were cultivated in six-well plates and treated with LL-37 (0.5 M), poly 
(I:C) (0.1 g/ml) or their combination for 24 hours. NHEKs were then infected with 
HSV-1 (MOI=2) and incubated for 1 hour at 37 C to allow virus adsorption. The 
culture medium was then replaced with newly prepared medium containing -globulin 
(5 mg/ml) (Gammagard, Baxter Healthcare Corp, West Village, CA, U.S.A.). 
Forty-eight hours later, the viral plaque formation was visualized by crystal violet 
staining.  
 
Confocal laser scanning microscopy analysis 
NHEKs were treated with poly (I:C)-conjugated with FITC (2 g/ml) in the presence or 
absence of LL-37 (10 M) for 6 hours. Then the uptake of FITC-conjugated poly (I:C) 
was observed by confocal laser scanning microscopy (LSM780, Zeiss, Jena, Germany) 
in Central Research Laboratory, Okayama University Medical School. Nuclei were 
visualized with 4’-6-diamidino-2-phenylidole (DAPI).  
 
Statistical analysis 
All statistical analyses were conducted by using Graph Pad prism, version 4.03. 
Student’s t-test was used for statistical analysis and a value of p<0.05 was considered 
significant. 
 
Results 
LL-37 and poly (I:C) synergistically induce IFN-β expression in NHEKs. 
In order to investigate the effect of LL-37 on TLR3 signaling in keratinocytes, we 
stimulated NHEKs with a TLR3 ligand, poly (I:C), in the presence or absence of LL-37. 
LL-37 and poly (I:C) in combination synergistically induced a higher IFNB1 mRNA 
compared with LL-37 or poly (I:C) alone (Fig. 1a).11 Furthermore, we also analyzed 
other cytokines and chemokines. IL6 and IL8  mRNA expression was also 
synergistically induced but a chemokine CCL5 expression was significantly suppressed 
as recently reported by Chen et al. (Fig.1b-d)13 A corresponding increase of IFN- 
protein was also confirmed by ELISA (Fig.2a). A peak increase of IFNB1 mRNA or 
protein was observed 6 or 24 hours after the stimulation, respectively (Fig. 2b-c). In 
addition, the expression of IFNB1 mRNA was up-regulated by poly (I:C) and LL-37 in 
a dose-dependent manner (Fig. 2d-e). 
 
LL-37 enhances anti-viral activity against HSV-1 induced by poly (I:C).  
Poly (I:C)-induced TLR3 signaling is reported to enhance anti-viral activity in 
keratinocytes.15 To investigate whether LL-37 could further up-regulate the anti-viral 
activity induced by TLR3 signaling, a virus plaque assay using herpes simplex virus 
type 1 (HSV-1) was performed. Although poly (I:C) or LL-37 alone significantly 
reduced the viral plaque numbers, the co-stimulation with LL-37 and poly (I:C) further 
decreased them compared with poly (I:C) or LL-37 alone (Fig. 3).  
 
LL-37 does not increase the expression of poly (I:C) receptors.  
Previously we reported that TLR9 expression is up-regulated by LL-37 in keratinocytes, 
and this up-regulation enhances TLR9 responsiveness.11 Therefore we next examined if 
TLR3 expression could be induced by LL-37 at various concentrations in NHEKs. 
Unlike TLR9 expression, TLR3 expression was not increased by LL-37 although IFN- 
and IL-29 significantly induced it in NHEKs as previously reported. (Fig. 4a)16,17 We 
also analyzed whether LL-37 affects the poly (I:C)-induced up-regulation of expression 
of TLR3. Poly (I:C) induced TLR3 expression as previously described, but LL-37 did 
not change the up-regulation (Fig. 4b).18 We further investigated the effect of LL-37 on 
other ds-RNA sensors RIG-I (DDX58) and MDA5 (IFIH1) expression in NHEKs. 
Similar to TLR3, the expression of these receptors was also significantly induced by 
IFN-α and IL-29, but not by LL-37 (Fig. 4c, d).  
 
The uptake of poly (I:C) into cells is increased by LL-37. 
We next hypothesized that the uptake of poly (I:C) into the cells could be enhanced by 
LL-37, because nucleic acids are negatively charged and can easily bind to LL-37, and 
also because LL-37 can change the structure of the cell membrane.19,20 To examine this 
hypothesis, we cultured NHEKs treated with poly (I:C) conjugated with FITC in the 
presence or absence of LL-37. 
As shown in Fig 3, the addition of LL-37 increased dot-like FITC-conjugated poly (I:C) 
in the cytoplasm or on the cell membrane (Fig. 5), which suggests that LL-37 could 
increase the uptake of poly (I:C). 
 
TLR3 and LL-37 expression is increased in keratinocytes surrounding herpetic 
vesicles. 
The in vitro experiment suggested that TLR3 and LL-37 could affect keratinocytes in 
cutaneous viral infection. As expected, immunohistochemical analysis revealed that 
keratinocytes around herpetic vesicles abundantly expressed TLR3 and LL-37 
compared with keratinocytes from normal skin. TLR3- or LL-37-positive cells were 
also seen in the vesicles and the dermis of lesional skin (Fig. 6a-d). 
  
Discussion 
Antimicrobial peptides (AMPs) play an essential role in innate immunity against 
invasion of infectious agents, including bacteria, viruses, fungi and parasites. AMPs not 
only display antimicrobial activity but also play multiple roles in immune defense, 
including neutralization of endotoxins, chemokine-like activities, immunomodulating 
activities, and induction of both angiogenesis and wound repair.21-23 Today, more than 
2200 AMPs have been identified (The Antimicrobial Peptides Database: 
http://aps.unmc.edu/AP/main.php). LL-37 also affects the production of 
proinflammatory cytokines/chemokines in various types of cells through the activation 
of multiple receptors.24 TLR3, TLR7/TLR8 and TLR9 are activated by viral 
double-stranded DNA, viral single-stranded RNA, and bacterial CpG, respectively, and 
these receptors are located within the endosome or other intracellular compartments. 
5,8,25 LL-37 has been reported to form a complex with self-DNA and RNA, enhances 
DNA uptake into intracellular compartments, and stimulates TLR9- and 
TLR7-dependent overproduction of IFNs, which are the key mediator of myeloid 
dendritic cells activation in psoriasis.26,27 On the other hand, other groups have reported 
that TLR3 signaling is modulated by LL-37 in several types of cells.12,13,28 In this study, 
we showed that LL-37 enhances IFN- expression and anti-viral activity induced by 
poly (I:C) in keratinocytes.20 Interestingly, IL6 and IL8 mRNA expression was similarly 
induced but that of CCL5 was significantly suppressed as previously described13.  So 
far these modulation mechanisms have been not clarified well, thus further 
investigations are need to explain the difference of modulation among cytokines and 
chemokines.  
Other dsRNA sensors, MDA5 and RIG-I, also might be involved in anti-HSV 
activity in keratinocytes. However, in our experiments, we simply added poly (I:C) into 
cultured media. Since MDA5 and RIG-I are located in the cytosol, transfection 
techniques should be needed to bind poly (I:C) to MDA5 and RIG-I. Therefore, we 
focused on TLR3 as dsRNA sensor in this study, and considered two possibilities of the 
enhancement of IFN- induction by poly (I:C); (1) the expression of poly (I:C) receptor 
TLR3 was up-regulated by LL-37 and (2) the uptake of poly (I:C) into the cells was 
enhanced by LL-37. To investigate the first scenario, we examined whether LL-37 could 
affect TLR3 expression in NHEKs. However, we found that the expression was not 
changed by LL-37. Previously, our group reported that LL-37 increased TLR9 
expression in normal human keratinocytes.11 The reason for the differential effects of 
LL-37 on TLR3 and TLR9 expression was not clear, because the mechanism of the 
induction is still not studied well. On the other hand, CLSM analysis showed that LL-37 
enhanced the uptake of poly (I:C) into the cells. This result is consistent with previous 
studies showing that the antimicrobial peptide LL-37 is one protein that stabilizes and 
enhances uptake of self-nucleic acids into dendritic cells.26,27 One of the reasons why 
LL-37 enhances the uptake of poly (I:C) might be associated with the previous report 
that the presence of LL-37 effectively protects plasmid DNA against degradation by 
serum nuclease and targets DNA plasmid to the nuclei of mammalian cells through 
caveolae-independent membrane raft endocytosis and cell surface proteoglycans.29 On 
the other hand, the complex of DNA and LL-37 did not show a synergistic effect in 
keratinocytes.11 Another possibility could be that LL-37 changes the structure of the cell 
membrane and thereby alters the efficacy of endocytosis. The mechanism of 
keratinocyte uptake into the endosome might be different from that of plasmacytoid 
dendritic cells or macrophages. Further investigations are needed to understand this 
mechanism.  
Viral plaque assay revealed that LL-37 or poly (I:C) alone significantly 
suppressed HSV plaque formation. Poly (I:C)-induced TLR3 signaling is reported to 
enhance anti-viral activity in keratinocytes, and an antimicrobial peptide LL-37 itself 
can kill the virus as already reported.15,30 But the combination of LL-37 and poly (I:C) 
further decreased the viral plaque numbers compared with poly (I:C) or LL-37 alone. 
Since the combination of LL-37 and poly (I:C) synergistically induce IFN- expression, 
the induction might enhance anti-viral activity in keratinocytes.  
Immunohistochemical analysis showed increases in TLR3 and LL-37 
expression in keratinocytes around herpetic vesicles. TLR3, a sensor of viral 
double-stranded RNA,8 is an essential component of innate immunity in cutaneous viral 
infection.31,32 Herpes simplex virus type 1 (HSV-1) is a double-stranded DNA virus but 
produces double-stranded RNA in infected cells.10,33 On the other hand, TLR3 has been 
reported to recognize the double-stranded domains of self-RNA from damaged 
keratinocytes after injury or ultraviolet radiation.34,35 Therefore, TLR3 might recognize 
not only viral RNA but also self-RNA released from degenerated keratinocytes in viral 
vesicles. In addition, it has recently been reported that TLR3 is vital for innate immunity 
to HSV-1 in the central nervous system.36-38 Taken together with these evidences, our 
findings suggest that TLR3 and LL-37 could play an important role in skin viral 
infections such as herpes simplex. Herpes simplex often reoccurs, although acyclovir 
has been used effectively to suppress virus proliferation at the clinical level. Targeting 
TLR3 signaling and LL-37 might provide a new approach to the treatment of herpes 
simplex.   
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Figure legends 
Fig. 1. (a-d) NHEKs were stimulated with LL-37 (5 M), poly (I:C) (1.0 g/ml) or their 
combination for 24 hours. IFNB1, IL6, IL8, and CCL5 mRNA expression was analyzed 
by quantitative real-time PCR. *P<0.05, **P<0.01. Data are the means  SEM of 
triplicate samples and representative of three independent experiments. 
 
Fig.2. (a) NHEKs were stimulated with LL-37 (5 M), poly (I:C) (1.0 g/ml) or their 
combination for 24 hours. IFN- protein in the media was analyzed by ELISA. (b,c) 
NHEKs were stimulated with the combination of LL-37 (5 M) and poly (I:C) (1.0 
g/ml) for 3 to 48 hours, and then the expressions of IFNB1 mRNA  and  IFN- 
protein were analyzed by quantitative real-time PCR and ELISA. (d, e) NHEKs were 
treated with LL-37 (2-8 M), poly (I:C) (0.1 to 10 g/ml) or their combination for 24 
hours and then the expression of IFNB1 mRNA was analyzed by quantitative real-time 
PCR. *P<0.05. Data are the means ± SEM of triplicate samples and representative of 
two independent experiments. 
 
Fig. 3. NHEKs were treated with LL-37 (0.5 M), poly (I:C) (0.1 g/ml) or their 
combination for 24 hours and then infected by HSV-1 for 48 hours. Viral plaque 
formation was visualized by crystal violet staining. ***, p<0.001. Data are the means  
SEM of triplicate samples and representative of three independent experiments. 
 
Fig. 4. (a,c,d) NHEKs were treated with LL-37 (0.1-10 M) for 24 hours. (b) NHEKs 
were stimulated with LL-37 (5 M), poly (I:C) (1.0 g/ml) or their combination for 24 
hours. TLR3, DDX58 and IFIH1 mRNA expression was examined by quantitative 
real-time PCR. *P<0.05, **P<0.01, ***P<0.001. Data are the means  SEM of 
triplicate samples and representative of three independent experiments. 
 
Fig. 5. NHEKs were treated with poly (I:C) conjugated with FITC (2 M) in the 
presence or absence of LL-37 (10 M) for 6 hours, and the uptake of poly (I:C) was 
examined by immunofluorescence. Nuclei were visualized with 
4’-6-diamidino-2-phenylidole (DAPI) (scale bar =20 m). 
 
Fig. 6. (a-d) TLR3 and LL37 expression was examined by immunohistochemistry in 
lesional skin from herpes simplex (a, c) or normal skin (b, d). Data shown are from a 
single sample representative of three (scale bar =200 m). 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
